Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML

LEUKEMIA

NATURE PUBLISHING GROUP

1. US National Cancer Institute (NCI) [NIH R35 CA210030]
2. Children's Leukemia Research Foundation (CLRF)
3. Koch Institute for Integrative Cancer Research at MIT
4. Dana-Farber-Harvard Cancer Center (DF-HCC)
5. ERC Starting Grant (H2020)
6. ATIP-AVENIR French research program
7. LNCC French research program
8. St. Louis Association for leukemia research
9. Philippe Foundation fellowship
10. GPM fellowship
11. EHA research grant